Infectious Disease, Influenza, Pneumonia, Bacterial, Zoster; Herpes
Conditions
Keywords
Vaccine, Educational intervention, Senior Center Model of Care, Older adults
Brief summary
The study consists of two arms (PHARM and PEER) designed to educate participants about three vaccine-preventable diseases (zoster, pneumonia, and influenza) and vaccination. PHARM will consist of a 60-minute presentation about the three vaccine-preventable diseases and their vaccinations delivered by a pharmacist, featuring a didactic lecture and discussion supplemented by video clips of community members discussing their experiences around vaccination, as well as physicians underscoring the importance of vaccination. PEER will consist of a 60-minute small-group session led by a peer educator which includes scripted roleplaying exercises designed to reinforce learnings pertaining to these three vaccine-preventable diseases and their vaccinations. The components of these interventions will be designed to address specific barriers to vaccination identified by literature search and our prior work in the area of community-based vaccine education. Both arms will focus primarily on pneumococcal disease and zoster but will include limited content on influenza because participants are likely to have questions about how the flu and its vaccination differ from pneumococcal diseases and zoster. The study will be implemented in an older, predominantly African-American (AA) population, consistent with our prior work in this area.
Detailed description
In the pharmacist-led (PHARM) intervention group, participants will be given a 60-minute formal didactic presentation on vaccine-preventable diseases and vaccination. This presentation will be designed to address knowledge and beliefs related to zoster, pneumonia, and influenza, as well as barriers to receiving vaccination. It will be delivered by a pharmacist, will be appropriate for the participants' educational level, and will aim to establish an understanding of vaccine-preventable illnesses. The presentation will specifically discuss the following: causes, symptoms and potential complications of infections in the three diseases of interest (pneumococcal disease, zoster, and influenza); risk factors for developing the infections; incidence and prevalence of each disease of interest; modes of transmission; and disease prevention through vaccination. To improve the interactivity of the presentation, brief 30-60 second video clips excerpted from interviews with community members and physicians will be shown. Community member clips will consist of older adults from the African-American (AA) population who have experienced vaccine-preventable infections. These clips will provide culturally relevant testimony to the program audience and reinforce participant understanding of concepts introduced during didactic teaching. In the peer-led (PEER) intervention, peer educators will be recruited from an experienced cohort of peer educators at our senior center partner site. A pharmacist will train the peer educators about vaccine-preventable diseases over the course of two didactic sessions. Following this training, a third session will be held to train the peer educators on the script that they will deliver to participants. The script will include the key learning points to be taught by the peer educators to participants about vaccine preventable diseases and vaccination. The script will also include roleplay exercises. In the roleplay exercises, 3 scripted vaccination-related scenarios (one for each disease of interest) will be acted out by participants to illustrate scenarios participants might encounter when interacting with healthcare providers or friends/family. The skit and roleplay exercises will be practiced as needed, under the leadership of the senior center's project manager, to ensure that the peer educators are confident and consistent when delivering PEER. After completing the training, peer educators' competency on PEER program content will be assessed through a formal multiple-choice knowledge test. Each peer educator must achieve a minimum score of 80% correct over all items assessed, and 100% correct for all items deemed core knowledge. Once peer educator competency has been established, each peer educator will deliver PEER through a 60-minute small group session. During this session, peer educators will deliver the educational objectives through an informal discussion and will lead the group through the roleplay exercises. Participants will then be asked what key points they learned about vaccine-preventable diseases and vaccines. Finally, the peer educator will engage in a dialogue to clarify and summarize these key points. Objectives are: 1. Compare the efficacy of PHARM vs. PEER at improving participant's knowledge regarding vaccine-preventable diseases 2. Compare the efficacy of PHARM vs. PEER at improving participants' beliefs about vaccination 3. Measure the costs of PHARM and PEER from the senior center perspective 4. Compare the percent of participants taking activation step(s) to get vaccinated following receipt of PHARM vs. PEER 5. Determine the extent to which participants are satisfied with and trust the PHARM vs. PEER interventions Hypotheses supporting these objective are: 1. PHARM and PEER will achieve similar improvements in older adults' knowledge of vaccine preventable diseases (primary hypothesis) 2. PHARM and PEER will improved beliefs about vaccine-preventable disease 3. PEER will be a lower cost approach to educating participants in the senior center compared to PHARM 4. PHARM and PEER will result in similar rates of participants taking one or more activation step(s) to obtain vaccination 5. Participants will be highly satisfied with the PHARM and PEER interventions
Interventions
BEHAVIORALPharmacist-led Intervention (PHARM)
60 minute didactic lecture about vaccinations.
BEHAVIORALPeer-led Intervention (PEER)
60 minute peer led small group intervention including skits and other educational material
Sponsors
Merck Sharp & Dohme LLC
Thomas Jefferson University
Rutgers, The State University of New Jersey
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE
Intervention model description
The design is a randomized trial with randomization to PHARM or PEER performed at the program date level.
Eligibility
Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Age ≥50; * Can attend a 2-hour session (though both PHARM and PEER entail 60 minutes of intervention, an additional hour is needed to allow for informed consent and data collection); * Speak and read English at ≥4th grade level as determined by a brief reading passage; * Cognitively intact as evidenced by an Abbreviated Mental Status Test score ≥7.
Exclusion criteria
* Failure to meet inclusion criteria * Failure to give informed consent to participate in the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Measured at baseline (BL), immediately post-intervention (PT), and 1 month follow-up (1M) | Knowledge and awareness about the target vaccine-preventable diseases was assessed at each timepoint using the VEPSC Knowledge Instrument, a 3-section, 22-item instrument categorical response instrument. Scores consist of number of correct responses to the questions on the knowledge instrument, thus a higher score indicates better performance. Four scores are possible: three disease-specific subscores (one each for pneumonia, influenza, and zoster) and one total score (equaling the sum of the three disease-specific subscores). Possible score ranges are as follows: pneumonia 0-7; influenza 0-7; zoster 0-8; total 0-22. For each score type, pairwise score differences were calculated between all 3 timepoints (baseline, post-test, and one-month follow-up). Positive values indicate increased knowledge among participants; negative values indicate decreased knowledge. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cost Analysis | Measured after completion of all programs in both groups (an average of one year). | Measure the program costs of PHARM and PEER from the senior center perspective. Costs were measured in total for each group, and per-participant costs were calculated by dividing total group cost by group sample size. Outcome measure type is thus reported as number rather than choosing measures of central tendency and dispersion/precision (i.e., there are no standard deviations, confidence intervals, or ranges with this methodology). |
| Number of Participants Reporting Program Satisfaction | Measured immediately post-intervention (PT) and at 1 month follow-up (1M) | Satisfaction was assessed on the post-intervention and one-month follow-up surveys using two statements that were each scored on a 4-point Likert scale (1-Completely disagree, 2-Somewhat disagree, 3-Somewhat agree, 4-Completely agree). The statements were: 1) The educational program kept me interested or engaged and 2) I was satisfied with the content of the educational program. At each timepoint, responses were dichotomized as agree (comprising the Somewhat agree and Completely agree response options) and disagree (comprising the Somewhat disagree and Completely disagree response options), and these dichotomous responses were compared between PHARM and PEER via Fisher's exact test. |
| Number of Participants Planning to Receive Each Vaccine | Measured at baseline (BL), immediately post-intervention (PT), and 1 month follow-up (1M) | Compare the number of participants planning to receive vaccine in PHARM vs. PEER at each timepoint as assessed by the activation questionnaire |
| Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Measured at baseline (BL), immediately post-intervention (PT), and 1 month follow-up (1M) | Beliefs about vaccine-preventable diseases and vaccination were assessed via agreement with 5 statements scored on a 4-point Likert scale (1-Completely disagree, 2-Somewhat disagree, 3-Somewhat agree, 4-Completely agree) at each timepoint. The changes in beliefs between baseline, post-intervention, and the one-month follow-up were assessed in both PHARM and PEER groups. Pairwise Wilcoxon Signed-Rank tests were run comparing within-group changes in beliefs across timepoints and applying the Bonferroni correction (α=0.05/3=0.0167). |
| Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Baseline, immediately post-intervention, and 1 month follow-up | Compare the number of participants planning to discuss vaccines with doctor, pharmacist, or family/friends in PHARM vs. PEER at each timepoint |
| Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | One-month follow-up (1M) | Compare the number of participants reporting that they have discussed vaccines with their doctor, pharmacist, or family/friends at the one-month follow-up for PHARM vs. PEER |
| Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Measured at baseline (BL), immediately post-intervention (PT), and 1 month follow-up (1M) | Compare the number participants reporting positive vaccination status in PHARM vs. PEER at each timepoint as assessed by the activation questionnaire |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Pharmacist-led Intervention (PHARM) In the PHARM intervention group, participants will be given a 60-minute formal presentation on vaccine-preventable diseases to address knowledge and beliefs related to zoster, pneumonia, and influenza and to address barriers to receiving vaccination. In several studies, it has been demonstrated that those who believe it is wise to receive vaccinations and those that have discussed vaccination with their healthcare provider are more likely to receive a vaccine.
Pharmacist-led Intervention (PHARM): 60 minute didactic lecture about vaccinations. | 147 |
| Peer-led Intervention (PEER) A pharmacist will train the peer educators about vaccine-preventable diseases over the course of two didactic sessions. Following this training, a third session will be held to train the peer educators on the script that they will deliver to participants. The script will include the key learning points to be taught by the peer educators to participants about vaccine preventable diseases and vaccination. The script will also include role-play exercises. In the role-play exercises, 3 vaccination-related scenarios (one for each disease- zoster, pneumonia, and influenza) will be delivered to illustrate situations participants might encounter when interacting with healthcare providers or friends/family.
Peer-led Intervention (PEER): 60 minute peer led small group intervention including skits and other educational material | 140 |
| Total | 287 |
Baseline characteristics
| Characteristic | Total | Peer-led Intervention (PEER) | Pharmacist-led Intervention (PHARM) |
|---|---|---|---|
| Age, Continuous | 74.5 years STANDARD_DEVIATION 8.94 | 73.9 years STANDARD_DEVIATION 8.67 | 75.2 years STANDARD_DEVIATION 9.17 |
| Baseline Knowledge Scores Influenza Knowledge Score (# correct out of 7) | 4.8 Scores on a scale STANDARD_DEVIATION 1.66 | 4.8 Scores on a scale STANDARD_DEVIATION 1.63 | 4.8 Scores on a scale STANDARD_DEVIATION 1.69 |
| Baseline Knowledge Scores Pneumonia Knowledge Score (# correct out of 7) | 3.3 Scores on a scale STANDARD_DEVIATION 2.04 | 3.4 Scores on a scale STANDARD_DEVIATION 2.05 | 3.1 Scores on a scale STANDARD_DEVIATION 2.03 |
| Baseline Knowledge Scores Total Knowledge Score (number correct out of 22) | 11.8 Scores on a scale STANDARD_DEVIATION 4.81 | 12.0 Scores on a scale STANDARD_DEVIATION 4.82 | 11.6 Scores on a scale STANDARD_DEVIATION 4.8 |
| Baseline Knowledge Scores Zoster Knowledge Score (number correct out of 8) | 3.85 Scores on a scale STANDARD_DEVIATION 1.97 | 3.9 Scores on a scale STANDARD_DEVIATION 1.96 | 3.8 Scores on a scale STANDARD_DEVIATION 1.99 |
| Difficulty paying for basic necessities I don't know / not sure | 5 Participants | 2 Participants | 3 Participants |
| Difficulty paying for basic necessities I prefer not to answer / No response | 21 Participants | 6 Participants | 15 Participants |
| Difficulty paying for basic necessities Not difficult at all | 118 Participants | 61 Participants | 57 Participants |
| Difficulty paying for basic necessities Not very difficult | 64 Participants | 31 Participants | 33 Participants |
| Difficulty paying for basic necessities Somewhat difficult | 60 Participants | 29 Participants | 31 Participants |
| Difficulty paying for basic necessities Very difficult | 19 Participants | 11 Participants | 8 Participants |
| Highest degree of education achieved College graduate | 62 Participants | 32 Participants | 30 Participants |
| Highest degree of education achieved High school graduate or GED | 116 Participants | 55 Participants | 61 Participants |
| Highest degree of education achieved I prefer not to answer / No response | 33 Participants | 12 Participants | 21 Participants |
| Highest degree of education achieved Some college or vocational school | 76 Participants | 41 Participants | 35 Participants |
| Marital Status Divorced, not currently married | 54 Participants | 29 Participants | 25 Participants |
| Marital Status I don't know / Not sure | 1 Participants | 0 Participants | 1 Participants |
| Marital Status I prefer not to answer / No response | 11 Participants | 5 Participants | 6 Participants |
| Marital Status Married or living as married | 46 Participants | 25 Participants | 21 Participants |
| Marital Status Never married | 48 Participants | 22 Participants | 26 Participants |
| Marital Status Separated | 16 Participants | 10 Participants | 6 Participants |
| Marital Status Widowed, not currently married | 111 Participants | 49 Participants | 62 Participants |
| Race/Ethnicity, Customized Asian | 8 Participants | 1 Participants | 7 Participants |
| Race/Ethnicity, Customized Black | 183 Participants | 115 Participants | 68 Participants |
| Race/Ethnicity, Customized I don't know / Not sure | 1 Participants | 0 Participants | 1 Participants |
| Race/Ethnicity, Customized I prefer not to answer / No response | 8 Participants | 3 Participants | 5 Participants |
| Race/Ethnicity, Customized Latino | 3 Participants | 3 Participants | 0 Participants |
| Race/Ethnicity, Customized Other | 7 Participants | 2 Participants | 5 Participants |
| Race/Ethnicity, Customized White | 77 Participants | 16 Participants | 61 Participants |
| Region of Enrollment United States | 287 participants | 140 participants | 147 participants |
| Sex/Gender, Customized Female | 231 Participants | 113 Participants | 118 Participants |
| Sex/Gender, Customized I prefer not to answer / No response | 5 Participants | 1 Participants | 4 Participants |
| Sex/Gender, Customized Male | 51 Participants | 26 Participants | 25 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 0 | 0 / 0 |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |
Outcome results
Primary
Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases
Knowledge and awareness about the target vaccine-preventable diseases was assessed at each timepoint using the VEPSC Knowledge Instrument, a 3-section, 22-item instrument categorical response instrument. Scores consist of number of correct responses to the questions on the knowledge instrument, thus a higher score indicates better performance. Four scores are possible: three disease-specific subscores (one each for pneumonia, influenza, and zoster) and one total score (equaling the sum of the three disease-specific subscores). Possible score ranges are as follows: pneumonia 0-7; influenza 0-7; zoster 0-8; total 0-22. For each score type, pairwise score differences were calculated between all 3 timepoints (baseline, post-test, and one-month follow-up). Positive values indicate increased knowledge among participants; negative values indicate decreased knowledge.
Time frame: Measured at baseline (BL), immediately post-intervention (PT), and 1 month follow-up (1M)
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Pharmacist-led Intervention (PHARM) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to Post Test score change - Total | 3.5 Scores on a scale | Standard Deviation 4.03 |
| Pharmacist-led Intervention (PHARM) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to Post Test score change - Zoster | 1.3 Scores on a scale | Standard Deviation 1.85 |
| Pharmacist-led Intervention (PHARM) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to Post Test score change - Pneumonia | 1.5 Scores on a scale | Standard Deviation 1.89 |
| Pharmacist-led Intervention (PHARM) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to Post Test change - Influenza | 0.5 Scores on a scale | Standard Deviation 1.38 |
| Pharmacist-led Intervention (PHARM) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to 1 month follow up change - Total | 3.4 Scores on a scale | Standard Deviation 4.22 |
| Pharmacist-led Intervention (PHARM) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to 1 month follow up change - Zoster | 1.3 Scores on a scale | Standard Deviation 1.97 |
| Pharmacist-led Intervention (PHARM) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to 1 month follow up change - Pneumonia | 1.5 Scores on a scale | Standard Deviation 1.83 |
| Pharmacist-led Intervention (PHARM) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to 1 month follow up change - Influenza | 0.5 Scores on a scale | Standard Deviation 1.49 |
| Pharmacist-led Intervention (PHARM) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Post test to 1 month follow up change - Total | -0.15 Scores on a scale | Standard Deviation 2.26 |
| Pharmacist-led Intervention (PHARM) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Post test to 1 month follow up change - Zoster | -0.03 Scores on a scale | Standard Deviation 0.9 |
| Pharmacist-led Intervention (PHARM) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Post test to 1 month follow up change - Pneumonia | -0.09 Scores on a scale | Standard Deviation 1.94 |
| Pharmacist-led Intervention (PHARM) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Post test to 1 month follow up change - Influenza | -0.03 Scores on a scale | Standard Deviation 0.89 |
| Peer-led Intervention (PEER) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Post test to 1 month follow up change - Pneumonia | -0.4 Scores on a scale | Standard Deviation 1.76 |
| Peer-led Intervention (PEER) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to Post Test score change - Total | 4.9 Scores on a scale | Standard Deviation 4.25 |
| Peer-led Intervention (PEER) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to 1 month follow up change - Pneumonia | 1.5 Scores on a scale | Standard Deviation 2.22 |
| Peer-led Intervention (PEER) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to Post Test score change - Zoster | 1.8 Scores on a scale | Standard Deviation 1.86 |
| Peer-led Intervention (PEER) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Post test to 1 month follow up change - Zoster | -0.2 Scores on a scale | Standard Deviation 1.46 |
| Peer-led Intervention (PEER) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to Post Test score change - Pneumonia | 1.9 Scores on a scale | Standard Deviation 1.97 |
| Peer-led Intervention (PEER) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to 1 month follow up change - Influenza | 1.2 Scores on a scale | Standard Deviation 1.83 |
| Peer-led Intervention (PEER) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to Post Test change - Influenza | 1.1 Scores on a scale | Standard Deviation 1.58 |
| Peer-led Intervention (PEER) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Post test to 1 month follow up change - Influenza | 0.04 Scores on a scale | Standard Deviation 0.6973 |
| Peer-led Intervention (PEER) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to 1 month follow up change - Total | 4.3 Scores on a scale | Standard Deviation 4.82 |
| Peer-led Intervention (PEER) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Post test to 1 month follow up change - Total | -0.6 Scores on a scale | Standard Deviation 3.51 |
| Peer-led Intervention (PEER) | Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases | Baseline to 1 month follow up change - Zoster | 1.5 Scores on a scale | Standard Deviation 2.04 |
Comparison: Testing total knowledge score change between groups from baseline to post interventionp-value: 0.0081Wilcoxon (Mann-Whitney)
Comparison: Testing zoster knowledge score change between groups from baseline to post interventionp-value: 0.0243Wilcoxon (Mann-Whitney)
Comparison: Testing pneumonia knowledge score change between groups from baseline to post interventionp-value: 0.071Wilcoxon (Mann-Whitney)
Comparison: Testing influenza knowledge score change between groups from baseline to post interventionp-value: 0.0008Wilcoxon (Mann-Whitney)
Comparison: Testing total knowledge score change between groups from baseline to one-month follow-upp-value: 0.1094Wilcoxon (Mann-Whitney)
Comparison: Testing zoster knowledge score change between groups from baseline to one-month follow-upp-value: 0.2029Wilcoxon (Mann-Whitney)
Comparison: Testing pneumonia knowledge score change between groups from baseline to one-month follow-upp-value: 0.8599Wilcoxon (Mann-Whitney)
Comparison: Testing influenza knowledge score change between groups from baseline to one-month follow-upp-value: 0.0007Wilcoxon (Mann-Whitney)
Comparison: Testing total knowledge score change between groups from post-intervention to one-month follow-upp-value: 0.0246Wilcoxon (Mann-Whitney)
Comparison: Testing zoster knowledge score change between groups from post-intervention to one-month follow-upp-value: 0.078Wilcoxon (Mann-Whitney)
Comparison: Testing pneumonia knowledge score change between groups from post-intervention to one-month follow-upp-value: 0.0167Wilcoxon (Mann-Whitney)
Comparison: Testing influenza knowledge score change between groups from post-intervention to one-month follow-upp-value: 0.9417Wilcoxon (Mann-Whitney)
Secondary
Cost Analysis
Measure the program costs of PHARM and PEER from the senior center perspective. Costs were measured in total for each group, and per-participant costs were calculated by dividing total group cost by group sample size. Outcome measure type is thus reported as number rather than choosing measures of central tendency and dispersion/precision (i.e., there are no standard deviations, confidence intervals, or ranges with this methodology).
Time frame: Measured after completion of all programs in both groups (an average of one year).
| Arm | Measure | Group | Value (NUMBER) |
|---|---|---|---|
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Supplies cost | 256.13 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Refreshment costs | 1550.00 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Total cost in dollars | 7392.94 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Total cost per participant | 50.29 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Total cost per session | 1232.16 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Total senior center cost | 2488.98 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Total senior center cost per participant | 16.93 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Staff cost (community health worker) | 417.49 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Staff cost (PEER Leaders/Pharmacists) | 1109.14 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Staff cost (Program Director) | 327.33 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Staff cost (Senior center director) | 0 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Total staff cost | 1853.96 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Total staff cost per participant | 12.61 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Total staff cost per session | 308.99 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Travel costs | 378.89 Dollars |
| Pharmacist-led Intervention (PHARM) | Cost Analysis | Space costs | 1500 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Space costs | 3000 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Staff cost (PEER Leaders/Pharmacists) | 1960.00 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Refreshment costs | 1390.00 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Supplies cost | 256.13 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Total staff cost per participant | 35.35 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Total cost in dollars | 14887.45 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Staff cost (Program Director) | 769.92 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Total cost per participant | 106.34 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Travel costs | 342.92 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Total cost per session | 1240.62 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Staff cost (Senior center director) | 281.24 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Total senior center cost | 5548.25 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Total staff cost per session | 412.43 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Total senior center cost per participant | 39.63 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Total staff cost | 4949.20 Dollars |
| Peer-led Intervention (PEER) | Cost Analysis | Staff cost (community health worker) | 1938.04 Dollars |
Secondary
Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire
Compare the number of participants reporting that they have discussed vaccines with their doctor, pharmacist, or family/friends at the one-month follow-up for PHARM vs. PEER
Time frame: One-month follow-up (1M)
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Pharmacist-led Intervention (PHARM) | Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | Discussed with doctor at 1M | Yes | 22 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | Discussed with doctor at 1M | No response | 125 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | Discussed with pharmacist at 1M | Yes | 7 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | Discussed with pharmacist at 1M | No response | 140 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | Discussed with family/friends at 1M | Yes | 9 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | Discussed with family/friends at 1M | No response | 138 Participants |
| Peer-led Intervention (PEER) | Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | Discussed with family/friends at 1M | Yes | 24 Participants |
| Peer-led Intervention (PEER) | Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | Discussed with doctor at 1M | Yes | 62 Participants |
| Peer-led Intervention (PEER) | Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | Discussed with pharmacist at 1M | No response | 117 Participants |
| Peer-led Intervention (PEER) | Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | Discussed with doctor at 1M | No response | 78 Participants |
| Peer-led Intervention (PEER) | Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | Discussed with family/friends at 1M | No response | 116 Participants |
| Peer-led Intervention (PEER) | Number of Participants Having Discussed Vaccines With Others at One-month Follow-up as Assessed by the Activation Questionnaire | Discussed with pharmacist at 1M | Yes | 23 Participants |
Comparison: Testing between-group differences in number of participants having discussed vaccines with their doctor at one-month follow-up via Chi-squared testp-value: <0.0001Chi-squared
Comparison: Testing between-group differences in number of participants having discussed vaccines with their pharmacist at one-month follow-up via Chi-squared testp-value: 0.0012Chi-squared
Comparison: Testing between-group differences in number of participants having discussed vaccines with their family/friends at one-month follow-up via Chi-squared testp-value: 0.0034Chi-squared
Secondary
Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire
Compare the number of participants planning to discuss vaccines with doctor, pharmacist, or family/friends in PHARM vs. PEER at each timepoint
Time frame: Baseline, immediately post-intervention, and 1 month follow-up
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with doctor at BL | Yes | 66 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with doctor at BL | No response | 81 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with doctor at PT | Yes | 98 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with doctor at PT | No response | 49 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with doctor at 1M | Yes | 112 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with doctor at 1M | No response | 35 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with pharmacist at BL | Yes | 15 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with pharmacist at BL | No response | 132 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with pharmacist at PT | Yes | 30 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with pharmacist at PT | No response | 117 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with pharmacist at 1M | Yes | 38 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with pharmacist at 1M | No response | 109 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with family/friends at BL | Yes | 14 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with family/friends at BL | No response | 133 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with family/friends at PT | Yes | 30 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with family/friends at PT | No response | 117 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with family/friends at 1M | Yes | 39 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with family/friends at 1M | No response | 108 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with family/friends at BL | No response | 127 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with doctor at BL | Yes | 67 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with pharmacist at PT | No response | 104 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with doctor at BL | No response | 73 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with family/friends at 1M | No response | 80 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with doctor at PT | Yes | 95 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with pharmacist at 1M | Yes | 61 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with doctor at PT | No response | 45 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with family/friends at PT | Yes | 32 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with doctor at 1M | Yes | 120 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with pharmacist at 1M | No response | 79 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with doctor at 1M | No response | 20 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with family/friends at 1M | Yes | 60 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with pharmacist at BL | Yes | 19 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with family/friends at BL | Yes | 13 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with pharmacist at BL | No response | 121 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with family/friends at PT | No response | 108 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Discuss Vaccines With Others as Assessed by the Activation Questionnaire | Planning to discuss with pharmacist at PT | Yes | 36 Participants |
Comparison: Testing between-group differences in number of participants planning to discuss vaccines with their doctor at baseline via Chi-squared testp-value: 0.6153Chi-squared
Comparison: Testing between-group differences in number of participants planning to discuss vaccines with their doctor post-intervention via Chi-squared testp-value: 0.8299Chi-squared
Comparison: Testing between-group differences in number of participants planning to discuss vaccines with their doctor at one-month follow-up via Chi-squared testp-value: 0.0405Chi-squared
Comparison: Testing between-group differences in number of participants planning to discuss vaccines with their pharmacist at baseline via Chi-squared testp-value: 0.3776Chi-squared
Comparison: Testing between-group differences in number of participants planning to discuss vaccines with their pharmacist post-intervention via Chi-squared testp-value: 0.2856Chi-squared
Comparison: Testing between-group differences in number of participants planning to discuss vaccines with their pharmacist at one-month follow-up via Chi-squared testp-value: 0.0016Chi-squared
Comparison: Testing between-group differences in number of participants planning to discuss vaccines with their family/friends at baseline via Chi-squared testp-value: 0.9449Chi-squared
Comparison: Testing between-group differences in number of participants planning to discuss vaccines with their family/friends post-intervention via Chi-squared testp-value: 0.6143Chi-squared
Comparison: Testing between-group differences in number of participants planning to discuss vaccines with their family/friends at one-month follow-up via Chi-squared testp-value: 0.0036Chi-squared
Secondary
Number of Participants Planning to Receive Each Vaccine
Compare the number of participants planning to receive vaccine in PHARM vs. PEER at each timepoint as assessed by the activation questionnaire
Time frame: Measured at baseline (BL), immediately post-intervention (PT), and 1 month follow-up (1M)
Population: Rows labeled Those without history of \[...\] vaccine contain a subgroup analysis of those participants not reporting a positive vaccination history at post-test.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at BL | Planning to receive vaccine | 26 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at BL | Not planning to receive vaccine | 46 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at BL | No response | 75 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at PT | Planning to receive vaccine | 44 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at PT | Not planning to receive vaccine | 38 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at PT | No response | 65 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at 1M | Planning to receive vaccine | 46 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at 1M | Not planning to receive vaccine | 44 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at 1M | No response | 57 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at BL | Planning to receive vaccine | 22 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at BL | Not planning to receive vaccine | 25 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at BL | No response | 100 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at PT | Planning to receive vaccine | 35 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at PT | Not planning to receive vaccine | 26 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at PT | No response | 86 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at 1M | Planning to receive vaccine | 36 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at 1M | Not planning to receive vaccine | 27 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at 1M | No response | 84 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at BL | Planning to receive vaccine | 26 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at BL | Not planning to receive vaccine | 35 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at BL | No response | 86 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at PT | Planning to receive vaccine | 40 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at PT | Not planning to receive vaccine | 32 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at PT | No response | 75 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at 1M | Planning to receive vaccine | 45 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at 1M | Not planning to receive vaccine | 37 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at 1M | No response | 65 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of zoster vaccine (PT) | Planning to receive vaccine | 42 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of zoster vaccine (PT) | Not planning to receive vaccine | 37 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of zoster vaccine (PT) | No response | 14 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of zoster vaccine (1M) | Planning to receive vaccine | 39 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of zoster vaccine (1M) | Not planning to receive vaccine | 43 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of zoster vaccine (1M) | No response | 11 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of influenza vaccine (PT) | Planning to receive vaccine | 32 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of influenza vaccine (PT) | Not planning to receive vaccine | 26 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of influenza vaccine (PT) | No response | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of influenza vaccine (1M) | Planning to receive vaccine | 31 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of influenza vaccine (1M) | Not planning to receive vaccine | 27 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of influenza vaccine (1M) | No response | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of pneumonia vaccine (PT) | Planning to receive vaccine | 35 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of pneumonia vaccine (PT) | Not planning to receive vaccine | 29 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of pneumonia vaccine (PT) | No response | 11 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of pneumonia vaccine (1M) | Planning to receive vaccine | 34 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of pneumonia vaccine (1M) | Not planning to receive vaccine | 33 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Planning to Receive Each Vaccine | Those without history of pneumonia vaccine (1M) | No response | 8 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at PT | Not planning to receive vaccine | 28 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at BL | Planning to receive vaccine | 36 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of pneumonia vaccine (PT) | Planning to receive vaccine | 43 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at BL | Not planning to receive vaccine | 58 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at PT | No response | 57 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at BL | No response | 46 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of influenza vaccine (PT) | Not planning to receive vaccine | 28 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at PT | Planning to receive vaccine | 60 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at 1M | Planning to receive vaccine | 54 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at PT | Not planning to receive vaccine | 46 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of pneumonia vaccine (1M) | Planning to receive vaccine | 36 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at PT | No response | 34 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at 1M | Not planning to receive vaccine | 40 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at 1M | Planning to receive vaccine | 56 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of influenza vaccine (PT) | No response | 1 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at 1M | Not planning to receive vaccine | 57 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at 1M | No response | 46 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive zoster vaccine at 1M | No response | 27 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of pneumonia vaccine (PT) | Not planning to receive vaccine | 25 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at BL | Planning to receive vaccine | 30 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of zoster vaccine (PT) | Planning to receive vaccine | 59 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at BL | Not planning to receive vaccine | 36 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of influenza vaccine (1M) | Planning to receive vaccine | 38 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at BL | No response | 74 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of zoster vaccine (PT) | Not planning to receive vaccine | 45 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at PT | Planning to receive vaccine | 44 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of pneumonia vaccine (1M) | No response | 3 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at PT | Not planning to receive vaccine | 30 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of zoster vaccine (PT) | No response | 6 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at PT | No response | 66 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of influenza vaccine (1M) | Not planning to receive vaccine | 31 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at 1M | Planning to receive vaccine | 45 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of zoster vaccine (1M) | Planning to receive vaccine | 53 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at 1M | Not planning to receive vaccine | 36 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of pneumonia vaccine (PT) | No response | 3 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive influenza vaccine at 1M | No response | 59 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of zoster vaccine (1M) | Not planning to receive vaccine | 54 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at BL | Planning to receive vaccine | 35 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of influenza vaccine (1M) | No response | 0 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at BL | Not planning to receive vaccine | 35 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of zoster vaccine (1M) | No response | 3 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at BL | No response | 70 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of pneumonia vaccine (1M) | Not planning to receive vaccine | 32 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Planning to receive pneumonia vaccine at PT | Planning to receive vaccine | 55 Participants |
| Peer-led Intervention (PEER) | Number of Participants Planning to Receive Each Vaccine | Those without history of influenza vaccine (PT) | Planning to receive vaccine | 40 Participants |
Comparison: Testing between-group differences in number of participants planning to receive pneumonia vaccine at baseline via Chi-squared testp-value: 0.3985Chi-squared
Comparison: Testing between-group differences in number of participants planning to receive zoster vaccine at baseline via Chi-squared testp-value: 0.7728Chi-squared
Comparison: Testing between-group differences in number of participants planning to receive zoster vaccine post-intervention via Chi-squared testp-value: 0.6871Chi-squared
Comparison: Testing between-group differences in number of participants planning to receive zoster vaccine at one-month follow-up via Chi-squared testp-value: 0.8259Chi-squared
Comparison: Testing between-group differences in number of participants planning to receive influenza vaccine at baseline via Chi-squared testp-value: 0.8868Chi-squared
Comparison: Testing between-group differences in number of participants planning to receive influenza vaccine post-intervention via Chi-squared testp-value: 0.8069Chi-squared
Comparison: Testing between-group differences in number of participants planning to receive influenza vaccine at one-month follow-up via Chi-squared testp-value: 0.8489Chi-squared
Comparison: Testing between-group differences in number of participants planning to receive pneumonia vaccine post-intervention via Chi-squared testp-value: 0.1722Chi-squared
Comparison: Testing between-group differences in number of participants planning to receive pneumonia vaccine at one-month follow-up via Chi-squared testp-value: 0.7318Chi-squared
Comparison: Among those without positive vaccination history at post-test, testing between-group differences in number of participants planning to receive zoster vaccine post-intervention via Chi-squared testp-value: 0.6309Chi-squared
Comparison: Among those without positive vaccination history at post-test, testing between-group differences in number of participants planning to receive zoster vaccine at one-month follow-up via Chi-squared testp-value: 0.7881Chi-squared
Comparison: Among those without positive vaccination history at post-test, testing between-group differences in number of participants planning to receive influenza vaccine post-intervention via Chi-squared testp-value: 0.6798Chi-squared
Comparison: Among those without positive vaccination history at post-test, testing between-group differences in number of participants planning to receive influenza vaccine at one-month follow-up via Chi-squared testp-value: 0.8548Chi-squared
Comparison: Among those without positive vaccination history at post-test, testing between-group differences in number of participants planning to receive pneumonia vaccine post-intervention via Chi-squared testp-value: 0.3182Chi-squared
Comparison: Among those without positive vaccination history at post-test, testing between-group differences in number of participants planning to receive pneumonia vaccine at one-month follow-up via Chi-squared testp-value: 0.7986Chi-squared
Secondary
Number of Participants Reporting Positive Vaccination Status at Each Timepoint
Compare the number participants reporting positive vaccination status in PHARM vs. PEER at each timepoint as assessed by the activation questionnaire
Time frame: Measured at baseline (BL), immediately post-intervention (PT), and 1 month follow-up (1M)
Population: Rows labeled without previous \[...\] vaccine, contain a subgroup analysis of those participants not reporting a positive vaccination history at post-test.
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at BL | Yes | 65 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at PT | No response | 8 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at BL | No | 67 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at BL | No | 51 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at BL | No response | 15 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at PT | Yes | 54 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at PT | Yes | 72 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at BL | No response | 10 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at PT | No | 70 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at 1M | Yes | 52 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at PT | No response | 5 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at PT | Yes | 86 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at 1M | Yes | 69 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at BL | No response | 17 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at 1M | No | 75 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at PT | No | 60 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at 1M | No response | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at 1M | No | 88 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without zoster vaccine at PT (1M status) | Yes | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at PT | No response | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without zoster vaccine at PT (1M status) | No | 83 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at PT | No | 85 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without zoster vaccine at PT (1M status) | No response | 7 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at 1M | Yes | 89 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without influenza vaccine at PT (1M status) | Yes | 5 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at 1M | No response | 7 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without influenza vaccine at PT (1M status) | No | 55 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at 1M | No | 57 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without influenza vaccine at PT (1M status) | No response | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at BL | No | 80 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without pneumonia vaccine at PT (1M status) | Yes | 6 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at 1M | No response | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without pneumonia vaccine at PT (1M status) | No | 66 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at BL | Yes | 86 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without pneumonia vaccine at PT (1M status) | No response | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at BL | Yes | 50 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without pneumonia vaccine at PT (1M status) | No response | 1 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at BL | Yes | 32 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at BL | No | 98 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at BL | No response | 10 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at PT | Yes | 30 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at PT | No | 105 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at PT | No response | 5 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at 1M | Yes | 36 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at 1M | No | 103 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of zoster vaccine at 1M | No response | 1 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at BL | Yes | 70 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at BL | No | 66 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at BL | No response | 4 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at PT | Yes | 71 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at PT | No | 68 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at PT | No response | 1 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at 1M | Yes | 81 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at 1M | No | 59 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of influenza vaccine at 1M | No response | 0 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at BL | Yes | 59 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at BL | No | 75 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at BL | No response | 6 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at PT | Yes | 69 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at PT | No | 69 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at PT | No response | 2 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at 1M | Yes | 67 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at 1M | No | 72 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Reporting history of pneumonia vaccine at 1M | No response | 1 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without zoster vaccine at PT (1M status) | Yes | 10 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without zoster vaccine at PT (1M status) | No | 99 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without zoster vaccine at PT (1M status) | No response | 1 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without influenza vaccine at PT (1M status) | Yes | 17 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without influenza vaccine at PT (1M status) | No | 52 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without influenza vaccine at PT (1M status) | No response | 0 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without pneumonia vaccine at PT (1M status) | Yes | 14 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Positive Vaccination Status at Each Timepoint | Those without pneumonia vaccine at PT (1M status) | No | 56 Participants |
Comparison: Testing between-group differences in number of participants reporting positive history of zoster vaccine at baseline via Chi-squared testp-value: 0.0163Chi-squared
Comparison: Testing between-group differences in number of participants reporting positive history of zoster vaccine post-intervention via Chi-squared testp-value: 0.0028Chi-squared
Comparison: Testing between-group differences in number of participants reporting positive history of zoster vaccine at one-month follow-up via Chi-squared testp-value: 0.0433Chi-squared
Comparison: Testing between-group differences in number of participants reporting positive history of influenza vaccine at baseline via Chi-squared testp-value: 0.0592Chi-squared
Comparison: Testing between-group differences in number of participants reporting positive history of influenza vaccine post-intervention via Chi-squared testp-value: 0.1843Chi-squared
Comparison: Testing between-group differences in number of participants reporting positive history of influenza vaccine at one-month follow-up via Chi-squared testp-value: 0.5933Chi-squared
Comparison: Testing between-group differences in number of participants reporting positive history of pneumonia vaccine at baseline via Chi-squared testp-value: 0.3942Chi-squared
Comparison: Testing between-group differences in number of participants reporting positive history of pneumonia vaccine post-intervention via Chi-squared testp-value: 0.9062Chi-squared
Comparison: Testing between-group differences in number of participants reporting positive history of pneumonia vaccine at one-month follow-up via Chi-squared testp-value: 0.9618Chi-squared
Comparison: Among those without positive vaccination history at post-test, testing between-group differences in number of participants reporting positive history of zoster vaccine at one-month follow-up via Chi-squared testp-value: 0.114Chi-squared
Comparison: Among those without positive vaccination history at post-test, testing between-group differences in number of participants reporting positive history of influenza vaccine at one-month follow-up via Chi-squared testp-value: 0.0141Chi-squared
Comparison: Among those without positive vaccination history at post-test, testing between-group differences in number of participants reporting positive history of pneumonia vaccine at one-month follow-up via Chi-squared testp-value: 0.0457Chi-squared
Secondary
Number of Participants Reporting Program Satisfaction
Satisfaction was assessed on the post-intervention and one-month follow-up surveys using two statements that were each scored on a 4-point Likert scale (1-Completely disagree, 2-Somewhat disagree, 3-Somewhat agree, 4-Completely agree). The statements were: 1) The educational program kept me interested or engaged and 2) I was satisfied with the content of the educational program. At each timepoint, responses were dichotomized as agree (comprising the Somewhat agree and Completely agree response options) and disagree (comprising the Somewhat disagree and Completely disagree response options), and these dichotomous responses were compared between PHARM and PEER via Fisher's exact test.
Time frame: Measured immediately post-intervention (PT) and at 1 month follow-up (1M)
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Program Satisfaction | The program kept me interested or engaged - PT | Completely or somewhat agree | 124 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Program Satisfaction | The program kept me interested or engaged - PT | Completely or somewhat disagree | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Program Satisfaction | The program kept me interested or engaged - PT | No response | 21 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Program Satisfaction | The program kept me interested or engaged - 1M | Completely or somewhat agree | 130 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Program Satisfaction | The program kept me interested or engaged - 1M | Completely or somewhat disagree | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Program Satisfaction | The program kept me interested or engaged - 1M | No response | 14 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Program Satisfaction | I was satisfied with program content - PT | Completely or somewhat agree | 125 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Program Satisfaction | I was satisfied with program content - PT | Completely or somewhat disagree | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Program Satisfaction | I was satisfied with program content - PT | No response | 21 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Program Satisfaction | I was satisfied with program content - 1M | Completely or somewhat agree | 132 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Program Satisfaction | I was satisfied with program content - 1M | Completely or somewhat disagree | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Number of Participants Reporting Program Satisfaction | I was satisfied with program content - 1M | No response | 14 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Program Satisfaction | I was satisfied with program content - 1M | Completely or somewhat disagree | 0 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Program Satisfaction | The program kept me interested or engaged - PT | Completely or somewhat agree | 127 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Program Satisfaction | I was satisfied with program content - PT | Completely or somewhat agree | 125 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Program Satisfaction | The program kept me interested or engaged - PT | Completely or somewhat disagree | 3 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Program Satisfaction | I was satisfied with program content - 1M | Completely or somewhat agree | 138 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Program Satisfaction | The program kept me interested or engaged - PT | No response | 10 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Program Satisfaction | I was satisfied with program content - PT | Completely or somewhat disagree | 2 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Program Satisfaction | The program kept me interested or engaged - 1M | Completely or somewhat agree | 135 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Program Satisfaction | I was satisfied with program content - 1M | No response | 2 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Program Satisfaction | The program kept me interested or engaged - 1M | Completely or somewhat disagree | 2 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Program Satisfaction | I was satisfied with program content - PT | No response | 13 Participants |
| Peer-led Intervention (PEER) | Number of Participants Reporting Program Satisfaction | The program kept me interested or engaged - 1M | No response | 3 Participants |
Comparison: Testing between-group differences in dichotomous engagement in the program immediately post-intervention via Fisher's Exact testp-value: 1Fisher Exact
Comparison: Testing between-group differences in dichotomous engagement in the program at the one-month follow-up via Fisher's Exact testp-value: 0.6806Fisher Exact
Comparison: Testing between-group differences in dichotomous satisfaction with the program's content immediately post-intervention via Fisher's Exact testp-value: 1Fisher Exact
Comparison: Testing between-group differences in dichotomous satisfaction with the program's content at the one-month follow-up via Fisher's Exact testp-value: 0.4908Fisher Exact
Secondary
Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines
Beliefs about vaccine-preventable diseases and vaccination were assessed via agreement with 5 statements scored on a 4-point Likert scale (1-Completely disagree, 2-Somewhat disagree, 3-Somewhat agree, 4-Completely agree) at each timepoint. The changes in beliefs between baseline, post-intervention, and the one-month follow-up were assessed in both PHARM and PEER groups. Pairwise Wilcoxon Signed-Rank tests were run comparing within-group changes in beliefs across timepoints and applying the Bonferroni correction (α=0.05/3=0.0167).
Time frame: Measured at baseline (BL), immediately post-intervention (PT), and 1 month follow-up (1M)
| Arm | Measure | Group | Category | Value (COUNT_OF_PARTICIPANTS) |
|---|---|---|---|---|
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | Slightly decreased agreement (1-point decrease) | 6 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | Slightly improved agreement (1-point increase) | 19 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | No change in agreement | 111 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | No change in agreement | 112 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | Slightly improved agreement (1-point increase) | 9 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | Strongly improved agreement (3-point increase) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | Somewhat improved agreement (2-point increase) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | No response | 12 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | No response | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | Strongly decreased agreement (3-point decrease) | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | Strongly improved agreement (3-point increase) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | Somewhat decreased agreement (2-point decrease) | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | Slightly improved agreement (1-point increase) | 10 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | Slightly decreased agreement (1-point decrease) | 4 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | No response | 14 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | No change in agreement | 137 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | Slightly improved agreement (1-point increase) | 10 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | Slightly improved agreement (1-point increase) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | Strongly decreased agreement (3-point decrease) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | Somewhat improved agreement (2-point increase) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | Somewhat improved agreement (2-point increase) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | Strongly improved agreement (3-point increase) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | Somewhat decreased agreement (2-point decrease) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | No response | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | Strongly decreased agreement (3-point decrease) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | Strongly decreased agreement (3-point decrease) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | Slightly decreased agreement (1-point decrease) | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | Somewhat decreased agreement (2-point decrease) | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | Strongly decreased agreement (3-point decrease) | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | Slightly decreased agreement (1-point decrease) | 4 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | No change in agreement | 139 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | No change in agreement | 112 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | Somewhat improved agreement (2-point increase) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | Slightly improved agreement (1-point increase) | 12 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | Slightly improved agreement (1-point increase) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | Somewhat improved agreement (2-point increase) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | Somewhat decreased agreement (2-point decrease) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | Strongly improved agreement (3-point increase) | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | Somewhat improved agreement (2-point increase) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | No response | 15 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | Strongly improved agreement (3-point increase) | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | Strongly decreased agreement (3-point decrease) | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | Strongly improved agreement (3-point increase) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | Somewhat decreased agreement (2-point decrease) | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | Slightly decreased agreement (1-point decrease) | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | Slightly decreased agreement (1-point decrease) | 13 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | No response | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | No change in agreement | 99 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | Strongly improved agreement (3-point increase) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | Slightly improved agreement (1-point increase) | 12 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | Strongly decreased agreement (3-point decrease) | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | Somewhat improved agreement (2-point increase) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | No change in agreement | 108 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | Strongly improved agreement (3-point increase) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | Somewhat decreased agreement (2-point decrease) | 7 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | No response | 15 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | Somewhat decreased agreement (2-point decrease) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | Strongly decreased agreement (3-point decrease) | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | Slightly decreased agreement (1-point decrease) | 9 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | Somewhat decreased agreement (2-point decrease) | 4 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | Slightly improved agreement (1-point increase) | 19 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | Slightly decreased agreement (1-point decrease) | 7 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | No change in agreement | 79 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | No change in agreement | 129 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | No response | 12 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | Slightly improved agreement (1-point increase) | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | Slightly improved agreement (1-point increase) | 4 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | Somewhat improved agreement (2-point increase) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | Somewhat improved agreement (2-point increase) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | Strongly improved agreement (3-point increase) | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | Somewhat improved agreement (2-point increase) | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | Somewhat improved agreement (2-point increase) | 6 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | Strongly decreased agreement (3-point decrease) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | Strongly improved agreement (3-point increase) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | Somewhat decreased agreement (2-point decrease) | 5 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | Strongly improved agreement (3-point increase) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | Slightly decreased agreement (1-point decrease) | 7 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | Strongly decreased agreement (3-point decrease) | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | No change in agreement | 86 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | Strongly decreased agreement (3-point decrease) | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | Slightly improved agreement (1-point increase) | 19 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | No response | 14 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | Somewhat improved agreement (2-point increase) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | Somewhat decreased agreement (2-point decrease) | 7 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | Strongly improved agreement (3-point increase) | 3 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | Slightly decreased agreement (1-point decrease) | 6 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | No response | 23 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | Slightly decreased agreement (1-point decrease) | 12 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | Strongly decreased agreement (3-point decrease) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | Strongly decreased agreement (3-point decrease) | 1 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | Somewhat decreased agreement (2-point decrease) | 11 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | No change in agreement | 70 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | Slightly decreased agreement (1-point decrease) | 12 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | Somewhat decreased agreement (2-point decrease) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | No change in agreement | 74 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | Slightly improved agreement (1-point increase) | 6 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | Slightly improved agreement (1-point increase) | 19 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | Somewhat decreased agreement (2-point decrease) | 0 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | Somewhat improved agreement (2-point increase) | 4 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | Somewhat improved agreement (2-point increase) | 7 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | Strongly improved agreement (3-point increase) | 4 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | No response | 10 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | No response | 23 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | Strongly improved agreement (3-point increase) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | Strongly decreased agreement (3-point decrease) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | Slightly decreased agreement (1-point decrease) | 4 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | Somewhat decreased agreement (2-point decrease) | 7 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | No response | 40 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | Slightly decreased agreement (1-point decrease) | 7 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | Slightly decreased agreement (1-point decrease) | 10 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | No change in agreement | 114 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | Strongly decreased agreement (3-point decrease) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | Slightly improved agreement (1-point increase) | 4 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | No change in agreement | 107 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | Somewhat improved agreement (2-point increase) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | Somewhat decreased agreement (2-point decrease) | 2 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | Strongly improved agreement (3-point increase) | 5 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | No change in agreement | 117 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | No response | 6 Participants |
| Pharmacist-led Intervention (PHARM) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | No response | 40 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | No response | 7 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | Slightly improved agreement (1-point increase) | 15 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | Somewhat improved agreement (2-point increase) | 8 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | Strongly improved agreement (3-point increase) | 2 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | No response | 14 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | Strongly decreased agreement (3-point decrease) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | Somewhat decreased agreement (2-point decrease) | 2 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | Slightly decreased agreement (1-point decrease) | 5 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | No change in agreement | 102 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | Slightly improved agreement (1-point increase) | 19 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | Somewhat improved agreement (2-point increase) | 3 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | Strongly improved agreement (3-point increase) | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to PT) | No response | 8 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | Strongly decreased agreement (3-point decrease) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | Somewhat decreased agreement (2-point decrease) | 2 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | Slightly decreased agreement (1-point decrease) | 5 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | No change in agreement | 98 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | Slightly improved agreement (1-point increase) | 20 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | Somewhat improved agreement (2-point increase) | 6 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | Strongly decreased agreement (3-point decrease) | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | Somewhat decreased agreement (2-point decrease) | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | Slightly decreased agreement (1-point decrease) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | No change in agreement | 97 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | Slightly improved agreement (1-point increase) | 27 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | Somewhat improved agreement (2-point increase) | 5 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | Strongly improved agreement (3-point increase) | 2 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to PT) | No response | 8 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | Strongly decreased agreement (3-point decrease) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | Somewhat decreased agreement (2-point decrease) | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | Slightly decreased agreement (1-point decrease) | 2 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | No change in agreement | 94 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | Slightly improved agreement (1-point increase) | 28 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | Somewhat improved agreement (2-point increase) | 5 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | Strongly improved agreement (3-point increase) | 2 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (BL to 1M) | No response | 8 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | Strongly decreased agreement (3-point decrease) | 2 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | Somewhat decreased agreement (2-point decrease) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | Slightly decreased agreement (1-point decrease) | 6 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | No change in agreement | 122 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | Slightly improved agreement (1-point increase) | 8 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | Somewhat improved agreement (2-point increase) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | Strongly improved agreement (3-point increase) | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccinations are important for health (PT to 1M) | No response | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | Strongly decreased agreement (3-point decrease) | 7 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | Somewhat decreased agreement (2-point decrease) | 13 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | Slightly decreased agreement (1-point decrease) | 12 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | No change in agreement | 53 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | Slightly improved agreement (1-point increase) | 7 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | Somewhat improved agreement (2-point increase) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | Strongly improved agreement (3-point increase) | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to PT) | No response | 47 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | Strongly decreased agreement (3-point decrease) | 6 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | Somewhat decreased agreement (2-point decrease) | 13 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | Slightly decreased agreement (1-point decrease) | 21 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | No change in agreement | 38 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | Slightly improved agreement (1-point increase) | 11 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | Somewhat improved agreement (2-point increase) | 3 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | Strongly improved agreement (3-point increase) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (BL to 1M) | No response | 47 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | Strongly decreased agreement (3-point decrease) | 3 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | Somewhat decreased agreement (2-point decrease) | 5 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | Slightly decreased agreement (1-point decrease) | 10 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Vaccines are harmful to health (PT to 1M) | No change in agreement | 83 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | Strongly improved agreement (3-point increase) | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (BL to 1M) | No response | 8 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | Strongly decreased agreement (3-point decrease) | 3 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | Somewhat decreased agreement (2-point decrease) | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | Slightly decreased agreement (1-point decrease) | 6 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | No change in agreement | 115 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | Slightly improved agreement (1-point increase) | 10 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | Somewhat improved agreement (2-point increase) | 4 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | Strongly improved agreement (3-point increase) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in doctors as vaccine info source (PT to 1M) | No response | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | Strongly decreased agreement (3-point decrease) | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | Somewhat decreased agreement (2-point decrease) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | Slightly decreased agreement (1-point decrease) | 11 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | No change in agreement | 96 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | Slightly improved agreement (1-point increase) | 21 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | Somewhat improved agreement (2-point increase) | 3 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | Strongly improved agreement (3-point increase) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to PT) | No response | 7 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | Strongly decreased agreement (3-point decrease) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | Somewhat decreased agreement (2-point decrease) | 2 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | Slightly decreased agreement (1-point decrease) | 14 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | No change in agreement | 84 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | Slightly improved agreement (1-point increase) | 28 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | Somewhat improved agreement (2-point increase) | 4 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | Strongly improved agreement (3-point increase) | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (BL to 1M) | No response | 7 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | Strongly decreased agreement (3-point decrease) | 4 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | Somewhat decreased agreement (2-point decrease) | 2 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | Slightly decreased agreement (1-point decrease) | 13 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | No change in agreement | 98 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | Slightly improved agreement (1-point increase) | 19 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | Somewhat improved agreement (2-point increase) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | Strongly improved agreement (3-point increase) | 1 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in pharmacists for vaccine info (PT to 1M) | No response | 2 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | Strongly decreased agreement (3-point decrease) | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | Somewhat decreased agreement (2-point decrease) | 5 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | Slightly decreased agreement (1-point decrease) | 12 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | No change in agreement | 77 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | Slightly improved agreement (1-point increase) | 27 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | Somewhat improved agreement (2-point increase) | 3 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | Strongly improved agreement (3-point increase) | 0 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to PT) | No response | 16 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | Strongly decreased agreement (3-point decrease) | 3 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | Somewhat decreased agreement (2-point decrease) | 5 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | Slightly decreased agreement (1-point decrease) | 11 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | No change in agreement | 55 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | Slightly improved agreement (1-point increase) | 37 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | Somewhat improved agreement (2-point increase) | 7 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | Strongly improved agreement (3-point increase) | 6 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(BL to 1M) | No response | 16 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | Strongly decreased agreement (3-point decrease) | 4 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | Somewhat decreased agreement (2-point decrease) | 9 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | Slightly decreased agreement (1-point decrease) | 10 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | No change in agreement | 73 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | Slightly improved agreement (1-point increase) | 19 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | Somewhat improved agreement (2-point increase) | 9 Participants |
| Peer-led Intervention (PEER) | Within-Group Changes in Beliefs About Vaccine-Preventable Diseases and Vaccines | Trust in peer educators for vaccine info(PT to 1M) | Strongly improved agreement (3-point increase) | 9 Participants |
Comparison: Testing within-group changes in beliefs for the statement Getting vaccinations is important to my health from baseline to post-interventionp-value: 0.0011Sign test
Comparison: Testing within-group changes in beliefs for the statement Getting vaccinations is important to my health from baseline to post-interventionp-value: <0.0001Sign test
Comparison: Testing within-group changes in beliefs for the statement Getting vaccinations is important to my health from baseline to one-month follow-upp-value: 0.0028Sign test
Comparison: Testing within-group changes in beliefs for the statement Getting vaccinations is important to my health from baseline to one-month follow-upp-value: <0.0001Sign test
Comparison: Testing within-group changes in beliefs for the statement Getting vaccinations is important to my health from post-intervention to one-month follow-upp-value: 1Sign test
Comparison: Testing within-group changes in beliefs for the statement Getting vaccinations is important to my health from post-intervention to one-month follow-upp-value: 0.643Sign test
Comparison: Testing within-group changes in beliefs for the statement Getting vaccinations can be harmful to my health from baseline to post-interventionp-value: 0.1193Sign test
Comparison: Testing within-group changes in beliefs for the statement Getting vaccinations can be harmful to my health from baseline to post-interventionp-value: <0.0001Sign test
Comparison: Testing within-group changes in beliefs for the statement Getting vaccinations can be harmful to my health from baseline to one-month follow-upp-value: 0.4861Sign test
Comparison: Testing within-group changes in beliefs for the statement Getting vaccinations can be harmful to my health from baseline to one-month follow-upp-value: 0.0002Sign test
Comparison: Testing within-group changes in beliefs for the statement Getting vaccinations can be harmful to my health from post-intervention to one-month follow-upp-value: 0.3247Sign test
Comparison: Testing within-group changes in beliefs for the statement Getting vaccinations can be harmful to my health from post-intervention to one-month follow-upp-value: 0.4627Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust my doctor to give me information about vaccines and the diseases they prevent from baseline to post-interventionp-value: 0.1244Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust my doctor to give me information about vaccines and the diseases they prevent from baseline to post-interventionp-value: 0.0575Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust my doctor to give me information about vaccines and the diseases they prevent from baseline to one-month follow-upp-value: 0.7489Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust my doctor to give me information about vaccines and the diseases they prevent from baseline to one-month follow-upp-value: 0.0098Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust my doctor to give me information about vaccines and the diseases they prevent from post-intervention to one-month follow-upp-value: 0.1797Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust my doctor to give me information about vaccines and the diseases they prevent from post-intervention to one-month follow-upp-value: 0.3613Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust my pharmacist to give me information about vaccines and the diseases they prevent from baseline to post-interventionp-value: 0.5972Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust my pharmacist to give me information about vaccines and the diseases they prevent from baseline to post-interventionp-value: 0.024Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust my pharmacist to give me information about vaccines and the diseases they prevent from baseline to one-month follow-upp-value: 0.2437Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust my pharmacist to give me information about vaccines and the diseases they prevent from baseline to one-month follow-upp-value: 0.0631Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust my pharmacist to give me information about vaccines and the diseases they prevent from post-intervention to one-month follow-upp-value: 0.054Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust my pharmacist to give me information about vaccines and the diseases they prevent from post-intervention to one-month follow-upp-value: 0.7298Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust a peer educator to give me information about vaccines and the diseases they prevent from baseline to post-interventionp-value: 0.4218Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust a peer educator to give me information about vaccines and the diseases they prevent from baseline to post-interventionp-value: 0.2282Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust a peer educator to give me information about vaccines and the diseases they prevent from baseline to one-month follow-upp-value: 0.8711Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust a peer educator to give me information about vaccines and the diseases they prevent from baseline to one-month follow-upp-value: 0.0027Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust a peer educator to give me information about vaccines and the diseases they prevent from post-intervention to one-month follow-upp-value: 0.7579Sign test
Comparison: Testing within-group changes in beliefs for the statement I trust a peer educator to give me information about vaccines and the diseases they prevent from post-intervention to one-month follow-upp-value: 0.1299Sign test